Clinical Trial Update: To Evaluate the Impact of Treatment Interruption on Re-initiation of Bifeprunox [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update reporting completion of a study evaluating how treatment interruption affects re-initiation of bifeprunox in patients with schiz…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Bifeprunox (bifeprunox)

Snippet

Sponsor: Solvay Pharmaceuticals | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 2 | Status: COMPLETED